Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Menu

    Cefiderocol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 34,072Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shionogi Unveils Anti-Infective Portfolio Data at IDWeek
    Shionogi Unveils Anti-Infective Portfolio Data at IDWeek

    03 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-03/shionogi-to-present-new-data-from-anti-infective-portfolio-at-idweek

    PHARMAWEB
    03 Sep 2025
    Share Share
    Shionogi's cefiderocol improves outcomes in early gram-negative i
    Shionogi's cefiderocol improves outcomes in early gram-negative i

    30 Apr 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/shionogis-cefiderocol-shows-improved-outcomes-with-early-use-in-treating-gram-negative-infections-globaldata/

    EXPRESSPHARMA
    30 Apr 2025
    Share Share
    Shionogi Presents Real-World Evidence Study Of Cefiderocol At IDWeek
    Shionogi Presents Real-World Evidence Study Of Cefiderocol At IDWeek

    16 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016051716/en

    BUSINESSWIRE
    16 Oct 2024
    Share Share
    ESCMID 2024: Shionogi Presents Fetcroja Real-World Efficacy Data
    ESCMID 2024: Shionogi Presents Fetcroja Real-World Efficacy Data

    18 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240418017364/en

    BUSINESSWIRE
    18 Apr 2024
    Share Share
    Shionogi Presents Evidence Demonstrating Effectiveness of Fetroja
    Shionogi Presents Evidence Demonstrating Effectiveness of Fetroja

    11 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231010481450/en

    BUSINESSWIRE
    11 Oct 2023
    Share Share
    Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja
    Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja

    17 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230416005020/en

    BUSINESSWIRE
    17 Apr 2023
    Share Share